http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015175709-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47cc435e1d443f13180f7766df104d9d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c922650fb323bf9ccd5e5ca344996a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66064d9cd56eca5d3219a612980a2a32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce9401128d375902e274f53f539da227 |
| publicationDate | 2015-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2015175709-A |
| titleOfInvention | Standard cell solution |
| abstract | PROBLEM TO BE SOLVED: To provide a standard cell solution for confirming the staining performance of a treatment solution that separates CTC and leukocytes. A standard cell solution for confirming staining performance of a treatment solution for dyeing circulating cancer cells (CTC) and leukocytes in blood, comprising: (a) a cell line having an antigen specific for human cancer cells; b) a cell line comprising an antigen specific for human leukocytes and (c) an adsorption inhibitor, wherein (a) and (b) components are cell lines immobilized by a cell fixative. Cell fluid. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017135369-A |
| priorityDate | 2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.